Abstract
We report two cases of invasive infections due to Geosmithia argillacea, an emerging mold, in patients with chronic granulomatous disease receiving prolonged azole antifungal prophylaxis. One patient died despite receiving a combination of four antifungals, and the other developed cerebral and medullary lesions under a combination of caspofungin, posaconazole, terbinafine, and gamma interferon.
MeSH terms
-
Abscess / microbiology
-
Adolescent
-
Adult
-
Antifungal Agents / administration & dosage*
-
Azoles / administration & dosage*
-
Caspofungin
-
Chemoprevention / methods*
-
DNA, Fungal / chemistry
-
DNA, Fungal / genetics
-
DNA, Ribosomal Spacer / chemistry
-
DNA, Ribosomal Spacer / genetics
-
Echinocandins / administration & dosage
-
Eurotiales / classification
-
Eurotiales / isolation & purification*
-
Fatal Outcome
-
Female
-
Granulomatous Disease, Chronic / complications
-
Granulomatous Disease, Chronic / drug therapy*
-
Histocytochemistry
-
Humans
-
Interferon-gamma / administration & dosage
-
Lipopeptides
-
Male
-
Microscopy
-
Molecular Sequence Data
-
Mycoses / diagnosis*
-
Mycoses / microbiology
-
Naphthalenes / administration & dosage
-
Sequence Analysis, DNA
-
Terbinafine
-
Triazoles / administration & dosage
Substances
-
Antifungal Agents
-
Azoles
-
DNA, Fungal
-
DNA, Ribosomal Spacer
-
Echinocandins
-
Lipopeptides
-
Naphthalenes
-
Triazoles
-
posaconazole
-
Interferon-gamma
-
Caspofungin
-
Terbinafine
Associated data
-
GENBANK/HQ599538
-
GENBANK/HQ848389